Interview of Hervé Affagard, President of EMIH

We caught up with Hervé Affagard, CEO of MaaT Pharma and President of EMIH for an exclusive interview to discuss the far reaching impact of the ARES Phase 3 unprecedented results

Read the full interview below.

Hervé Affagard talks Phase 3 results, the regulatory landscape and industry collaborations

Register to Microbiome Times Partnering Forum: https://www.microbiomeforum.com/register